Molecular basis of amyloid deposition in myocardium: not only ATTR and AL. Case report

S. E. Andreeva, P. P. Snetkov, Yu. A. Vakhrushev, I. A. Piankov, O. O. Yaznevich, M. Bortsova, S. Morozkina, A. Kajava, A. Kostareva, M. Uspenskaya
{"title":"Molecular basis of amyloid deposition in myocardium: not only ATTR and AL. Case report","authors":"S. E. Andreeva, P. P. Snetkov, Yu. A. Vakhrushev, I. A. Piankov, O. O. Yaznevich, M. Bortsova, S. Morozkina, A. Kajava, A. Kostareva, M. Uspenskaya","doi":"10.18705/2311-4495-2022-9-6-26-35","DOIUrl":null,"url":null,"abstract":"Alterations in the proteostasis network and accumulation of misfolded protein aggregates — is one of the new pathogenesis concepts of chronic heart failure. We hypothesis in addition to well-known transthyretin (ATTR) and AL-amyloidosis some patients may represent amyloid lesion in myocardium came from undescribed amyloidogenic precursors due to misfolding of myocardial structural proteins.Here, we report on the case of patient with hypertrophic and restrictive phenotype of cardiomyopathy, biventricular heart failure, considered for heart transplant, and excluded known types of amyloidosis. Genetic testing revealed extended deletion in the gene of giant protein titin (TTN).We present with the use of bioinformatic analysis and molecular modeling how this mutation could lead to unfolding of corresponding protein and open its amyloidogenic motifs for intermolecular interactions, therefore, provide amyloidogenic ability. This data enables in more detail to decipher the pathogenesis of chronic heart failure on the background of cardiomyopathy, planning further studies for development of personalized risk profiling in different types of amyloidosis and elaborate more personalized treatment approach for such patients in the future.","PeriodicalId":89863,"journal":{"name":"Translational medicine (Sunnyvale, Calif.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational medicine (Sunnyvale, Calif.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18705/2311-4495-2022-9-6-26-35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Alterations in the proteostasis network and accumulation of misfolded protein aggregates — is one of the new pathogenesis concepts of chronic heart failure. We hypothesis in addition to well-known transthyretin (ATTR) and AL-amyloidosis some patients may represent amyloid lesion in myocardium came from undescribed amyloidogenic precursors due to misfolding of myocardial structural proteins.Here, we report on the case of patient with hypertrophic and restrictive phenotype of cardiomyopathy, biventricular heart failure, considered for heart transplant, and excluded known types of amyloidosis. Genetic testing revealed extended deletion in the gene of giant protein titin (TTN).We present with the use of bioinformatic analysis and molecular modeling how this mutation could lead to unfolding of corresponding protein and open its amyloidogenic motifs for intermolecular interactions, therefore, provide amyloidogenic ability. This data enables in more detail to decipher the pathogenesis of chronic heart failure on the background of cardiomyopathy, planning further studies for development of personalized risk profiling in different types of amyloidosis and elaborate more personalized treatment approach for such patients in the future.
心肌中淀粉样蛋白沉积的分子基础:不仅仅是ATTR和AL。病例报告
蛋白稳定网络的改变和错误折叠的蛋白质聚集体的积累——是慢性心力衰竭的新发病机制概念之一。我们假设,除了众所周知的转甲状腺素(ATTR)和AL淀粉样变性外,一些患者可能表示心肌中的淀粉样病变来自于心肌结构蛋白错误折叠导致的未描述的淀粉样变性前体。在此,我们报告了一例肥厚型和限制型心肌病患者,双心室心力衰竭,考虑进行心脏移植,并排除了已知类型的淀粉样变性。遗传测试显示,巨蛋白titin(TTN)基因存在延伸缺失。我们通过生物信息学分析和分子建模,介绍了这种突变如何导致相应蛋白质的去折叠,并打开其淀粉样蛋白基序进行分子间相互作用,从而提供淀粉样蛋白生成能力。这些数据使我们能够在心肌病的背景下更详细地解读慢性心力衰竭的发病机制,计划进一步研究不同类型淀粉样变性的个性化风险分析,并在未来为这些患者制定更个性化的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书